As expected, immunofluorescence revealed that the expression of ALDH1, Nanog, and CD49f was decreased while E-cadherin expression was increased in zoledronic acid-treated tumor tissues (Fig. 6d). The gene discussed is ALDH1A1; the disease is neoplasm.